143 related articles for article (PubMed ID: 35577124)
1. Penipentenone A and brefeldin A derivatives potently inhibit KRAS mutant cancer cells from an endophytic fungus Penicillium brefeldianum F4a.
Bai Y; Yi P; Li F; Hu J; Pan H
Phytochemistry; 2022 Aug; 200():113243. PubMed ID: 35577124
[TBL] [Abstract][Full Text] [Related]
2. Dibrefeldins A and B, A pair of epimers representing the first brefeldin A dimers with cytotoxic activities from Penicillium janthinellum.
Zeng F; Chen C; Al Chnani AA; Zhou Q; Tong Q; Wang W; Zang Y; Gong J; Wu Z; Liu J; Wang J; Zhu H; Zhang Y
Bioorg Chem; 2019 May; 86():176-182. PubMed ID: 30711700
[TBL] [Abstract][Full Text] [Related]
3. Peniapyrones A-I, Cytotoxic Tricyclic-Fused α-Pyrone Derivatives from an Endophytic
Bai Y; Ma X; Ren D; Yu G; Hu J; Hua H; Pan H
J Nat Prod; 2024 Jun; ():. PubMed ID: 38848113
[TBL] [Abstract][Full Text] [Related]
4. New analogues of brefeldin A from sediment-derived fungus Penicillium sp. DT-F29.
Hu ZF; Qin LL; Ding WJ; Liu Y; Ma ZJ
Nat Prod Res; 2016 Oct; 30(20):2311-5. PubMed ID: 27067647
[TBL] [Abstract][Full Text] [Related]
5. Discovery of ARS-1620 analogs as KRas G12C inhibitors with high in vivo antitumor activity.
Zhao H; Li L; Liu J; Mai R; Chen J; Chen J
Bioorg Chem; 2022 Apr; 121():105652. PubMed ID: 35158284
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel Quinazoline-based KRAS G12C inhibitors as potential anticancer agents.
Li L; Zhao H; Peng X; Liu J; Mai R; Chen J; Lin L; Chen T; Yan J; Shi J; Chen J
Bioorg Med Chem; 2022 Oct; 71():116962. PubMed ID: 35987104
[TBL] [Abstract][Full Text] [Related]
7. Penpolonin A-E, cytotoxic α-pyrone derivatives from Penicillium polonicum.
Ma Y; Wen Y; Cheng H; Deng J; Peng Y; Bahetejiang Y; Huang H; Wu C; Yang X; Pang K
Bioorg Med Chem Lett; 2021 May; 40():127921. PubMed ID: 33705907
[TBL] [Abstract][Full Text] [Related]
8. KRAS Inhibitors- yes but what next? Direct targeting of KRAS- vaccines, adoptive T cell therapy and beyond.
Nagasaka M; Potugari B; Nguyen A; Sukari A; Azmi AS; Ou SI
Cancer Treat Rev; 2021 Dec; 101():102309. PubMed ID: 34715449
[TBL] [Abstract][Full Text] [Related]
9. Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS
Wang X; Allen S; Blake JF; Bowcut V; Briere DM; Calinisan A; Dahlke JR; Fell JB; Fischer JP; Gunn RJ; Hallin J; Laguer J; Lawson JD; Medwid J; Newhouse B; Nguyen P; O'Leary JM; Olson P; Pajk S; Rahbaek L; Rodriguez M; Smith CR; Tang TP; Thomas NC; Vanderpool D; Vigers GP; Christensen JG; Marx MA
J Med Chem; 2022 Feb; 65(4):3123-3133. PubMed ID: 34889605
[TBL] [Abstract][Full Text] [Related]
10. Semi-Synthesis, Cytotoxic Evaluation, and Structure-Activity Relationships of Brefeldin A Derivatives with Antileukemia Activity.
Lu XX; Jiang YY; Wu YW; Chen GY; Shao CL; Gu YC; Liu M; Wei MY
Mar Drugs; 2021 Dec; 20(1):. PubMed ID: 35049881
[TBL] [Abstract][Full Text] [Related]
11. Not All Kirsten Rat Sarcoma Viral Oncogene Homolog Mutations Predict Poor Survival in Patients With Unresectable Colorectal Liver Metastasis.
Lin Z; Liu Y; Cai S; Yang C; Zhou L; Li W
Technol Cancer Res Treat; 2021; 20():15330338211039131. PubMed ID: 34669528
[No Abstract] [Full Text] [Related]
12. Novel Antioxidants and
Bai Y; Yi P; Zhang S; Hu J; Pan H
J Fungi (Basel); 2021 Oct; 7(11):. PubMed ID: 34829202
[TBL] [Abstract][Full Text] [Related]
13. Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer.
Brychta N; Krahn T; von Ahsen O
Clin Chem; 2016 Nov; 62(11):1482-1491. PubMed ID: 27591291
[TBL] [Abstract][Full Text] [Related]
14. Nine undescribed oxidized ergosterols from the endophytic fungus Penicillium herquei and their cytotoxic activity.
Deng M; Pu Y; Wan Z; Xu J; Huang S; Xie J; Zhou X
Phytochemistry; 2023 Aug; 212():113716. PubMed ID: 37156435
[TBL] [Abstract][Full Text] [Related]
15. Metabolic characterization of colorectal cancer cells harbouring different KRAS mutations in codon 12, 13, 61 and 146 using human SW48 isogenic cell lines.
Varshavi D; Varshavi D; McCarthy N; Veselkov K; Keun HC; Everett JR
Metabolomics; 2020 Apr; 16(4):51. PubMed ID: 32300895
[TBL] [Abstract][Full Text] [Related]
16. KRAS: A Promising Therapeutic Target for Cancer Treatment.
Wu HZ; Xiao JQ; Xiao SS; Cheng Y
Curr Top Med Chem; 2019; 19(23):2081-2097. PubMed ID: 31486755
[TBL] [Abstract][Full Text] [Related]
17. KRAS G12C-Mutant Non-Small Cell Lung Cancer: Biology, Developmental Therapeutics, and Molecular Testing.
Veluswamy R; Mack PC; Houldsworth J; Elkhouly E; Hirsch FR
J Mol Diagn; 2021 May; 23(5):507-520. PubMed ID: 33618059
[TBL] [Abstract][Full Text] [Related]
18. Five previously undescribed citrinin derivatives from the endophytic fungus Penicillium citrinum GZWMJZ-836.
Wang D; Wang H; Chen X; Xu Y; He W; Wu D; Zuo M; Zhu W; Wang L
Phytochemistry; 2024 Apr; 220():114032. PubMed ID: 38369172
[TBL] [Abstract][Full Text] [Related]
19. Five New Triene Derivatives from the Fungus Penicillium herquei JX4.
Luo ZW; Tang MM; Zhou XM; Song XM; Yi JL; Zhang B; Yang JY; Chen GY
Chem Biodivers; 2021 May; 18(5):e2100027. PubMed ID: 33738965
[TBL] [Abstract][Full Text] [Related]
20. Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations.
Lee J; Lee I; Han B; Park JO; Jang J; Park C; Kang WK
J Natl Cancer Inst; 2011 Apr; 103(8):674-88. PubMed ID: 21398618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]